{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for nonoxynol root_names_name in Any Name (approximate match)
Status:
Investigational
Source:
NCT03384745: Phase 2 Interventional Completed Psoriasis
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pivekimab sunirine [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03700294: Phase 1 Interventional Terminated Advanced Solid Tumors
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03729596: Phase 1/Phase 2 Interventional Terminated Squamous Cell Carcinoma of Head and Neck
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:trastuzumab envedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04620811: Phase 3 Interventional Completed Eosinophilic Gastritis
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02290951: Phase 1 Interventional Active, not recruiting Non-Hodgkin Lymphoma
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04612530: Phase 1 Interventional Unknown status Pancreatic Cancer
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04570839: Phase 1/Phase 2 Interventional Completed Endometrial Neoplasms
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03708211: Phase 1 Interventional Completed Neoplasms, Advanced Solid
(2019)
Source URL:
Class:
PROTEIN
